Copyright Reports & Markets. All rights reserved.

Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption 2014-2024
        • 2.1.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption CAGR by Region
      • 2.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Segment by Type
        • 2.2.1 Liquid
        • 2.2.2 Powder
      • 2.3 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Type
        • 2.3.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sale Price by Type (2014-2019)
      • 2.4 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Segment by Application
        • 2.4.1 EGF Cream
        • 2.4.2 EGF Lotion
        • 2.4.3 EGF Mask
        • 2.4.4 Other
      • 2.5 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Application
        • 2.5.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sale Price by Application (2014-2019)

      3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) by Players

      • 3.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Players
        • 3.1.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Players (2017-2019)
        • 3.1.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Players (2017-2019)
      • 3.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Players
        • 3.2.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Players (2017-2019)
        • 3.2.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Players (2017-2019)
      • 3.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sale Price by Players
      • 3.4 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Epidermal Growth Factor (EGF) (CAS 62253-63-8) Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Epidermal Growth Factor (EGF) (CAS 62253-63-8) by Regions

      • 4.1 Epidermal Growth Factor (EGF) (CAS 62253-63-8) by Regions
        • 4.1.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Regions
        • 4.1.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Value by Regions
      • 4.2 Americas Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption Growth
      • 4.3 APAC Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption Growth
      • 4.4 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption Growth
      • 4.5 Middle East & Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption Growth

      5 Americas

      • 5.1 Americas Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Countries
        • 5.1.1 Americas Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Countries (2014-2019)
        • 5.1.2 Americas Epidermal Growth Factor (EGF) (CAS 62253-63-8) Value by Countries (2014-2019)
      • 5.2 Americas Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Type
      • 5.3 Americas Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Countries
        • 6.1.1 APAC Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Countries (2014-2019)
        • 6.1.2 APAC Epidermal Growth Factor (EGF) (CAS 62253-63-8) Value by Countries (2014-2019)
      • 6.2 APAC Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Type
      • 6.3 APAC Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) by Countries
        • 7.1.1 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Countries (2014-2019)
        • 7.1.2 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Value by Countries (2014-2019)
      • 7.2 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Type
      • 7.3 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) by Countries
        • 8.1.1 Middle East & Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Type
      • 8.3 Middle East & Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Distributors
      • 10.3 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Customer

      11 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Forecast

      • 11.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Consumption Forecast (2019-2024)
      • 11.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Forecast by Regions
        • 11.2.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Forecast by Regions (2019-2024)
        • 11.2.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Forecast by Type
      • 11.8 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Forecast by Application

      12 Key Players Analysis

      • 12.1 Pavay
        • 12.1.1 Company Details
        • 12.1.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product Offered
        • 12.1.3 Pavay Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Pavay News
      • 12.2 Radiant
        • 12.2.1 Company Details
        • 12.2.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product Offered
        • 12.2.3 Radiant Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Radiant News
      • 12.3 BIO-FD&C
        • 12.3.1 Company Details
        • 12.3.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product Offered
        • 12.3.3 BIO-FD&C Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 BIO-FD&C News
      • 12.4 LipoTrue
        • 12.4.1 Company Details
        • 12.4.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product Offered
        • 12.4.3 LipoTrue Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 LipoTrue News
      • 12.5 BIOEFFECT
        • 12.5.1 Company Details
        • 12.5.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product Offered
        • 12.5.3 BIOEFFECT Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 BIOEFFECT News

      ...

        13 Research Findings and Conclusion

        Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival.

        EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that’s why most skin care maker use EGF to care our skin.

        And we only investigate the epidermal growth factor (EGF) cosmetic, take no account of the epidermal growth factor (EGF) for research use.

        The classification of Epidermal Growth Factor (EGF) includes liquid and powder. The proportion of liquid in 2016 is about 25%, the proportion of powder in 2016 is about 75%.

        The application of Epidermal Growth Factor (EGF) is divided into EGF Cream, EGF Lotion, EGF Mask and others. The most of Epidermal Growth Factor (EGF) is EGF Cream, and the market share of that is about 45% in 2016.

        Asia-Pacific is the largest consumption place, with a consumption market share nearly 34% in 2016. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 25% in 2016. And South America in the third largest consumption region with the consumption market share of 10%.

        Market competition is intense. Pavay, Radiant, BIO-FD&C, LipoTrue, BIOEFFECT are the leaders of the industry, with high-end customers in the industry.

        According to this study, over the next five years the Epidermal Growth Factor (EGF) (CAS 62253-63-8) market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 140 million by 2024, from US$ 110 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Epidermal Growth Factor (EGF) (CAS 62253-63-8) business, shared in Chapter 3.

        This report presents a comprehensive overview, market shares, and growth opportunities of Epidermal Growth Factor (EGF) (CAS 62253-63-8) market by product type, application, key manufacturers and key regions and countries.

        This study considers the Epidermal Growth Factor (EGF) (CAS 62253-63-8) value and volume generated from the sales of the following segments:

        Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
        Liquid
        Powder
        Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
        EGF Cream
        EGF Lotion
        EGF Mask
        Other

        This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
        Pavay
        Radiant
        BIO-FD&C
        LipoTrue
        BIOEFFECT
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global Epidermal Growth Factor (EGF) (CAS 62253-63-8) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
        To understand the structure of Epidermal Growth Factor (EGF) (CAS 62253-63-8) market by identifying its various subsegments.
        Focuses on the key global Epidermal Growth Factor (EGF) (CAS 62253-63-8) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the Epidermal Growth Factor (EGF) (CAS 62253-63-8) with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the consumption of Epidermal Growth Factor (EGF) (CAS 62253-63-8) submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now